BioNTech: "Pfizer COVID-19 Vaccine Effective Against UK Variant"

[Image source=Yonhap News]

[Asia Economy Reporter Yu Je-hoon] Pfizer and BioNTech's jointly developed novel coronavirus infection (COVID-19) vaccine has been reported to be effective against the UK variant, Bloomberg reported on the 20th (local time).

According to the report, a research team led by Ugur Sahin, CEO of BioNTech, stated in a research report related to antibodies collected from blood samples of 16 people vaccinated with the vaccine in Germany that "the possibility of the UK COVID-19 variant escaping from the (Pfizer) vaccine is very low."

Bloomberg explained that this study was conducted on 10 cultured variant viruses in the laboratory. Previously, Pfizer and the University of Texas jointly released research results showing that their vaccine is also effective against the South African COVID-19 variant.